Type II fibre atrophy and nuclear disruption in decompensated cirrhosis

Maryam Motamedrad; Maryam Ebadi; Norberto Sanchez-Fernandez; Alessandro Parente; Abha R. Dunichand-Hoedl; Elora Rider; Norman M. Kneteman; A.M. James Shapiro; David Bigam; Khaled Dajani; Blaire Anderson; Vickie E. Baracos; Vera Mazurak; Aldo J. Montano-Loza

doi:10.1016/j.jhepr.2025.101455

journal article Open Access Sep 01, 2025

Type II fibre atrophy and nuclear disruption in decompensated cirrhosis

Maryam Motamedrad Maryam Ebadi Norberto Sanchez-Fernandez

Alessandro Parente

Abha R. Dunichand-Hoedl

Elora Rider Norman M. Kneteman

A.M. James Shapiro

David Bigam Khaled Dajani

Blaire Anderson Vickie E. Baracos

Vera Mazurak Aldo J. Montano-Loza

JHEP Reports Vol. 7 No. 9 pp. 101455 · Elsevier BV

View at Publisher Save 10.1016/j.jhepr.2025.101455

Topics

No keywords indexed for this article. Browse by subject →

References

52

[1]

Tandon "Sarcopenia and frailty in decompensated cirrhosis" J Hepatol (2021) 10.1016/j.jhep.2021.01.025

[2]

Ebadi "Sarcopenia in cirrhosis: from pathogenesis to interventions" J Gastroenterol (2019) 10.1007/s00535-019-01605-6

[3]

Ebadi "Sarcopenia severity based on computed tomography image analysis in patients with cirrhosis" Nutrients (2020) 10.3390/nu12113463

[4]

Carey "A multicenter study to define sarcopenia in patients with end-stage liver disease" Liver Transpl (2017) 10.1002/lt.24750

[5]

Carey "A North American expert opinion statement on sarcopenia in liver transplantation" Hepatology (2019) 10.1002/hep.30828

[6]

Montano-Loza "Muscle wasting is associated with mortality in patients with cirrhosis" Clin Gastroenterol Hepatol (2012) 10.1016/j.cgh.2011.08.028

[7]

Montano-Loza "Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation" Liver Transpl (2014) 10.1002/lt.23863

[8]

Duong "The impact of frailty, sarcopenia, and malnutrition on liver transplant outcomes" Clin Liver Dis (Hoboken) (2021) 10.1002/cld.1043

[9]

Systematic Review and Meta-Analysis of the Impact of Computed Tomography–Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation

J.L.A. van Vugt, S. Levolger, R.W.F. de Bruin et al.

American Journal of Transplantation 2016 10.1111/ajt.13732

[10]

D'Amico "Clinical states of cirrhosis and competing risks" J Hepatol (2018) 10.1016/j.jhep.2017.10.020

[11]

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Paolo Angeli, Mauro Bernardi, Càndid Villanueva et al.

Journal of Hepatology 2018 10.1016/j.jhep.2018.03.024

[12]

Molwitz "Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation" Sci Rep (2023) 10.1038/s41598-023-33349-y

[13]

Brown "Cirrhosis-related sarcopenia may not resolve after liver transplantation" JHEP Rep (2023)

[14]

Martin "Investigation of the organelle pathology of skeletal muscle in chronic alcoholism" J Clin Pathol (1984) 10.1136/jcp.37.4.448

[15]

Martin "Alcoholic skeletal myopathy, a clinical and pathological study" Q J Med (1985)

[16]

Fernandez-Sola "Significance of type II fiber atrophy in chronic alcoholic myopathy" J Neurol Sci (1995) 10.1016/0022-510x(95)00005-m

[17]

Tsien "Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis" Hepatology (2015) 10.1002/hep.27717

[18]

Yin "Skeletal muscle atrophy: from mechanisms to treatments" Pharmacol Res (2021) 10.1016/j.phrs.2021.105807

[19]

Roman "Nuclear positioning in skeletal muscle" Semin Cell Dev Biol (2018) 10.1016/j.semcdb.2017.11.005

[20]

Bhullar "Lipid is heterogeneously distributed in muscle and associates with low radiodensity in cancer patients" J Cachexia Sarcopenia Muscle (2020) 10.1002/jcsm.12533

[21]

Freeman "The new liver allocation system: moving toward evidence-based transplantation policy" Liver Transpl (2002) 10.1053/jlts.2002.35927

[22]

Ebadi "Skeletal muscle pathological fat infiltration (myosteatosis) is associated with higher mortality in patients with cirrhosis" Cells (2022) 10.3390/cells11081345

[23]

Derstine "Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population" Sci Rep (2018) 10.1038/s41598-018-29825-5

[24]

Ebadi "Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis" JHEP Rep (2022)

[25]

Gallo "Effects of long-term creatine feeding and running on isometric functional measures and myosin heavy chain content of rat skeletal muscles" Pflugers Arch (2006) 10.1007/s00424-006-0079-0

[26]

Crosbie "Mdx muscle pathology is independent of nNOS perturbation" Hum Mol Genet (1998) 10.1093/hmg/7.5.823

[27]

Lexell "Human aging, muscle mass, and fiber type composition" J Gerontol A Biol Sci Med Sci (1995)

[28]

Kramer "Extensive type II muscle fiber atrophy in elderly female hip fracture patients" J Gerontol A Biol Sci Med Sci (2017) 10.1093/gerona/glw253

[29]

Wang "Mechanisms for fiber-type specificity of skeletal muscle atrophy" Curr Opin Clin Nutr Metab Care (2013)

[30]

Anoveros-Barrera "Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients" J Cachexia Sarcopenia Muscle (2019) 10.1002/jcsm.12466

[31]

Levit "Ethical framework for including research biopsies in oncology clinical trials: American society of clinical oncology research statement" J Clin Oncol (2019) 10.1200/jco.19.01479

[32]

Jungbluth "Centronuclear (myotubular) myopathy" Orphanet J Rare Dis (2008) 10.1186/1750-1172-3-26

[33]

Goodpaster "Intermuscular adipose tissue in metabolic disease" Nat Rev Endocrinol (2023) 10.1038/s41574-022-00784-2

[34]

Reichelt "Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation: potentially modifiable risk factors with major clinical impact" Liver Int (2024) 10.1111/liv.15917

[35]

Reichelt "Body composition and the skeletal muscle compartment in liver transplantation: turning challenges into opportunities" Am J Transpl (2022) 10.1111/ajt.17089

[36]

Czigany "Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation" Am J Transpl (2020) 10.1111/ajt.15577

[37]

Czigany "The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation" J Cachexia Sarcopenia Muscle (2021) 10.1002/jcsm.12669

[38]

Meister "Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation" Sci Rep (2021) 10.1038/s41598-021-92798-5

[39]

Goodpaster "Intramuscular lipid content is increased in obesity and decreased by weight loss" Metabolism (2000) 10.1016/s0026-0495(00)80010-4

[40]

Saiman "Frailty and sarcopenia in patients pre- and post-liver transplant" Clin Liver Dis (2021) 10.1016/j.cld.2020.08.004

[41]

Miarka "Sarcopenia-the impact on physical capacity of liver transplant patients" Life (Basel) (2021)

[42]

Bosoi "Attenuating hyperammonemia preserves protein synthesis and muscle mass via restoration of perturbed metabolic pathways in bile duct-ligated rats" Metab Brain Dis (2025) 10.1007/s11011-024-01525-2

[43]

Katayama "Possible pathogenetic role of ammonia in liver cirrhosis without hyperammonemia of venous blood: the so-called latency period of abnormal ammonia metabolism" Hepatol Res (2024) 10.1111/hepr.14022

[44]

Welch "Integrated multiomics analysis identifies molecular landscape perturbations during hyperammonemia in skeletal muscle and myotubes" J Biol Chem (2021) 10.1016/j.jbc.2021.101023

[45]

Jain "Long-term survival after liver transplantation in 4,000 consecutive patients at a single center" Ann Surg (2000) 10.1097/00000658-200010000-00004

[46]

Dunn "Physical function, physical activity, and quality of life after liver transplantation" Liver Transpl (2020) 10.1002/lt.25742

[47]

Bergerson "Liver transplantation arrests and reverses muscle wasting" Clin Transpl (2015) 10.1111/ctr.12506

[48]

Mazurak "Nutrition and the transplant candidate" Liver Transpl (2017) 10.1002/lt.24848

[49]

Leunis "Sarcopenia in end-stage liver disease and after liver transplantation" Acta Gastroenterol Belg (2023)

[50]

Ebadi "Current treatment strategies and future possibilities for sarcopenia in cirrhosis" J Hepatol (2023) 10.1016/j.jhep.2023.01.031

Showing 50 of 52 references

Metrics

1

Citations

52

References

Details

Published: Sep 01, 2025
Vol/Issue: 7(9)
Pages: 101455
License: View

Authors

Norberto Sanchez-Fernandez

A

Alessandro Parente

A

Abha R. Dunichand-Hoedl

Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada; Department of Surgery, University of Alberta, Edmonton, Alberta, Canada

Department of Oncology University of Alberta Edmonton Canada

Funding

Canada Foundation for Innovation

CIHR

University Hospital Foundation

Canadian Donation and Transplantation Research Program

Canadian Liver Foundation

Cite This Article

Maryam Motamedrad, Maryam Ebadi, Norberto Sanchez-Fernandez, et al. (2025). Type II fibre atrophy and nuclear disruption in decompensated cirrhosis. JHEP Reports, 7(9), 101455. https://doi.org/10.1016/j.jhepr.2025.101455

Type II fibre atrophy and nuclear disruption in decompensated cirrhosis

You May Also Like